• Explore /
  • Poster
  • / Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113, FUGA-BT).

Randomized phase III study of gemcitabine plus S-1 combination therapy versus gemcitabine plus cisplatin combination therapy in advanced biliary tract cancer: A Japan Clinical Oncology Group study (JCOG1113, FUGA-BT).

Abstract Poster

Authors

null

Makoto Ueno

Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Yokohama, Japan

Makoto Ueno , Chigusa Morizane , Takuji Okusaka , Junki Mizusawa , Hiroshi Katayama , Masafumi Ikeda , Masato Ozaka , Kazuya Sugimori , Akira Fukutomi , Hiroki Hara , Nobumasa Mizuno , Hiroaki Yanagimoto , Keiji Sano , Kazutoshi Tobimatsu , Kei Yane , Shoji Nakamori , Naohiro Sata , Seigo Yukisawa , Hiroshi Ishii , Junji Furuse

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

UMIN000010667

Citation

J Clin Oncol 36, 2018 (suppl; abstr 4014)

DOI

10.1200/JCO.2018.36.15_suppl.4014

Abstract #

4014

Poster Bd #

203

Abstract Disclosures

Similar Posters

First Author: Chigusa Morizane

First Author: Chigusa Morizane

First Author: Aiwu He

First Author: Satoshi Nara